Project Grant R34MH133684
Award Date
8/27/24
Completion Date
7/31/27
Dollars Obligated
$188K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
This federal Project Grant award, valued at $189,540, was issued by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program. The grant will support research at the University of Pittsburgh to characterize the independent and additive effects of schizophrenia and cannabis use on cannabinoid CB1 receptor expression and signaling in the brain, and the resulting impact on working memory. The research will utilize cross-species analyses,...
This Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $756,742 to Washington State University to conduct a hybrid type 1 effectiveness-implementation trial examining the integration of a culturally responsive Family Peer Delivered Engagement Strategy (FAMES) in Coordinated Specialty Care (CSC) programs across the U.S. The project aims to evaluate whether FAMES improves family member engagement in CSC...
This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $177,110 to the Cambridge Public Health Commission (doing business as Cambridge Health Alliance) to study the impact of cannabis legalization and commercialization on substance use and mental health outcomes among individuals with psychosis. The award will fund a multi-year research project that utilizes quasi-experimental...
The National Institute on Drug Abuse (NIDA) awarded a $445,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Children's Hospital Corporation (Boston Children's Hospital) to develop and pilot test a novel telehealth and mobile health intervention called MOMENT-V for treating cannabis use disorder in young adults. The intervention combines remote motivational enhancement therapy with ecological momentary interventions delivered via mobile app. The pilot...
This $376,078 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to explore the relationship between cannabis use for coping purposes and quantity/frequency of cannabis use. The 5-year study, set to commence on August 1, 2024, will be conducted by the University of Colorado. Key objectives include: Experimentally testing whether cannabis use increases after stress induction among...
This federal Project Grant award, ID R01DA059527, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,118,992 grant will fund a prospective investigation into the effects of cannabis use on reward and pain neurocircuits in adolescents with depression. The research aims to understand the relationships between cannabis use and depression in adolescence, which may inform prevention and intervention strategies for...
The National Institute of Mental Health (NIMH) awarded a Project Grant (CFDA 93.242) titled "Helping Guardians Navigate Youth Suicide Risk: Development and Piloting of a Brief Digital Intervention" to the University of Denver. The $256,627 award, with a project period from December 2024 to November 2027, aims to develop and test a digital single session intervention (SSI) and just-in-time (JIT) digital intervention for parents of pre- and early adolescents. The intervention seeks to...
This $311,000 federal Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop and pilot test a mobile-enhanced, web-based intervention for reducing cannabis use among non-college young adults (YAs) engaging in frequent or high-intensity cannabis use. The key products and services to be delivered through this 3-year project include: 1) Development of the "TAKE 5" intervention using focus groups...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under CFDA Program 93.242 Mental Health Research Grants, is funding a research project titled "Predicting Attenuated Psychotic Symptoms Amongst Youth Endorsing Persistent Distressing Psychotic-Like Experiences". The $738,037 award, granted on May 1, 2025, supports research aimed at improving early identification and prevention efforts for psychosis spectrum disorders. Key objectives include: 1)...